Market Analysis and Insights: Global Biological Drugs Market
The global Biological Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biological Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biological Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biological Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biological Drugs market.
Global Biological Drugs Scope and Market Size
The research report includes specific segments by region (country),
by company,
by Type and
by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Therapeutic Protein
- Monoclonal Antibody
- Vaccine
- Others
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
By Company
- Bristol-Myers Squibb
- Eli Lilly
- Takeda
- Pfizer
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- Abbott Laboratories
- Baxter
- Novartis
- Biogen
- GlaxoSmithKline
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Biological Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Biological Drugs, with price, sales, revenue, and global market share of Biological Drugs from 2019 to 2022.
Chapter 3, the Biological Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biological Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Drugs.
Chapter 13, 14, and 15, to describe Biological Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Biological Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Biological Drugs Market Overview
1.1 Product Overview and Scope of Biological Drugs
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Sales Growth Rate Comparison by Type (2023-2032)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Biological Drugs Segment by Application
1.3.1 Global Biological Drugs Sales Comparison by Application: (2023-2032)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global Biological Drugs Revenue 2018-2032
1.4.2 Global Biological Drugs Sales 2018-2032
1.4.3 Biological Drugs Market Size by Region: 2018 Versus 2022 Versus 2032
2 Biological Drugs Market Competition by Manufacturers
2.1 Global Biological Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biological Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Biological Drugs Manufacturing Sites, Area Served, Product Type
2.5 Biological Drugs Market Competitive Situation and Trends
2.5.1 Biological Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biological Drugs Players Market Share by Revenue
2.5.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Drugs Retrospective Market Scenario by Region
3.1 Global Biological Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Biological Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Biological Drugs Market Facts & Figures by Country
3.3.1 North America Biological Drugs Sales by Country
3.3.2 North America Biological Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biological Drugs Market Facts & Figures by Country
3.4.1 Europe Biological Drugs Sales by Country
3.4.2 Europe Biological Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biological Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Biological Drugs Sales by Region
3.5.2 Asia Pacific Biological Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biological Drugs Market Facts & Figures by Country
3.6.1 Latin America Biological Drugs Sales by Country
3.6.2 Latin America Biological Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biological Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Biological Drugs Sales by Country
3.7.2 Middle East and Africa Biological Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Biological Drugs Historic Market Analysis by Type
4.1 Global Biological Drugs Sales Market Share by Type (2018-2023)
4.2 Global Biological Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Biological Drugs Price by Type (2018-2023)
5 Global Biological Drugs Historic Market Analysis by Application
5.1 Global Biological Drugs Sales Market Share by Application (2018-2023)
5.2 Global Biological Drugs Revenue Market Share by Application (2018-2023)
5.3 Global Biological Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Eli Lilly Biological Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Takeda Biological Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Biological Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Amgen Biological Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Biological Drugs Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Merck Biological Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abbott Laboratories Biological Drugs Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Baxter Biological Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Biological Drugs Description and Business Overview
6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Biological Drugs Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Biological Drugs Description and Business Overview
6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Biogen Biological Drugs Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 GlaxoSmithKline
6.13.1 GlaxoSmithKline Corporation Information
6.13.2 GlaxoSmithKline Biological Drugs Description and Business Overview
6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio
6.13.5 GlaxoSmithKline Recent Developments/Updates
7 Biological Drugs Manufacturing Cost Analysis
7.1 Biological Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biological Drugs
7.4 Biological Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biological Drugs Distributors List
8.3 Biological Drugs Customers
9 Biological Drugs Market Dynamics
9.1 Biological Drugs Industry Trends
9.2 Biological Drugs Market Drivers
9.3 Biological Drugs Market Challenges
9.4 Biological Drugs Market Restraints
10 Global Market Forecast
10.1 Biological Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biological Drugs by Type (2023-2032)
10.1.2 Global Forecasted Revenue of Biological Drugs by Type (2023-2032)
10.2 Biological Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biological Drugs by Application (2023-2032)
10.2.2 Global Forecasted Revenue of Biological Drugs by Application (2023-2032)
10.3 Biological Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biological Drugs by Region (2023-2032)
10.3.2 Global Forecasted Revenue of Biological Drugs by Region (2023-2032)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Biological Drugs Sales Growth Rate Comparison by Type (2023-2032) & (K Units) & (US$ Million)
Table 2. Global Biological Drugs Sales Growth Rate Comparison by Application (2023-2032) & (K Units) & (US$ Million)
Table 3. Global Biological Drugs Market Size by Region (US$ Million) (2018 VS 2022 VS 2032)
Table 4. Global Biological Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global Biological Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Biological Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biological Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Biological Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Biological Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Biological Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Biological Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biological Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biological Drugs Sales by Region (2018-2023) & (K Units)
Table 16. Global Biological Drugs Sales Market Share by Region (2018-2023)
Table 17. Global Biological Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Biological Drugs Revenue Market Share by Region (2018-2023)
Table 19. North America Biological Drugs Sales by Country (2018-2023) & (K Units)
Table 20. North America Biological Drugs Sales Market Share by Country (2018-2023)
Table 21. North America Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Biological Drugs Revenue Market Share by Country (2018-2023)
Table 23. Europe Biological Drugs Sales by Country (2018-2023) & (K Units)
Table 24. Europe Biological Drugs Sales Market Share by Country (2018-2023)
Table 25. Europe Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Biological Drugs Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Biological Drugs Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Biological Drugs Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Biological Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Biological Drugs Revenue Market Share by Region (2018-2023)
Table 31. Latin America Biological Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Biological Drugs Sales Market Share by Country (2018-2023)
Table 33. Latin America Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Biological Drugs Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Biological Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Biological Drugs Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Biological Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Biological Drugs Revenue Market Share by Country (2018-2023)
Table 39. Global Biological Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Global Biological Drugs Sales Market Share by Type (2018-2023)
Table 41. Global Biological Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Biological Drugs Revenue Share by Type (2018-2023)
Table 43. Global Biological Drugs Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Biological Drugs Sales (K Units) by Application (2018-2023)
Table 45. Global Biological Drugs Sales Market Share by Application (2018-2023)
Table 46. Global Biological Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Biological Drugs Revenue Share by Application (2018-2023)
Table 48. Global Biological Drugs Price by Application (2018-2023) & (USD/Unit)
Table 49. Bristol-Myers Squibb Corporation Information
Table 50. Bristol-Myers Squibb Description and Business Overview
Table 51. Bristol-Myers Squibb Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Bristol-Myers Squibb Biological Drugs Product
Table 53. Bristol-Myers Squibb Recent Developments/Updates
Table 54. Eli Lilly Corporation Information
Table 55. Eli Lilly Description and Business Overview
Table 56. Eli Lilly Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Eli Lilly Biological Drugs Product
Table 58. Eli Lilly Recent Developments/Updates
Table 59. Takeda Corporation Information
Table 60. Takeda Description and Business Overview
Table 61. Takeda Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Takeda Biological Drugs Product
Table 63. Takeda Recent Developments/Updates
Table 64. Pfizer Corporation Information
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Pfizer Biological Drugs Product
Table 68. Pfizer Recent Developments/Updates
Table 69. Amgen Corporation Information
Table 70. Amgen Description and Business Overview
Table 71. Amgen Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Amgen Biological Drugs Product
Table 73. Amgen Recent Developments/Updates
Table 74. F. Hoffmann-La Roche Corporation Information
Table 75. F. Hoffmann-La Roche Description and Business Overview
Table 76. F. Hoffmann-La Roche Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. F. Hoffmann-La Roche Biological Drugs Product
Table 78. F. Hoffmann-La Roche Recent Developments/Updates
Table 79. Johnson & Johnson Corporation Information
Table 80. Johnson & Johnson Description and Business Overview
Table 81. Johnson & Johnson Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Johnson & Johnson Biological Drugs Product
Table 83. Johnson & Johnson Recent Developments/Updates
Table 84. Merck Corporation Information
Table 85. Merck Description and Business Overview
Table 86. Merck Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Merck Biological Drugs Product
Table 88. Merck Recent Developments/Updates
Table 89. Abbott Laboratories Corporation Information
Table 90. Abbott Laboratories Description and Business Overview
Table 91. Abbott Laboratories Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Abbott Laboratories Biological Drugs Product
Table 93. Abbott Laboratories Recent Developments/Updates
Table 94. Baxter Corporation Information
Table 95. Baxter Description and Business Overview
Table 96. Baxter Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Baxter Biological Drugs Product
Table 98. Baxter Recent Developments/Updates
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Business Overview
Table 101. Novartis Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Novartis Biological Drugs Product
Table 103. Novartis Recent Developments/Updates
Table 104. Biogen Corporation Information
Table 105. Biogen Description and Business Overview
Table 106. Biogen Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Biogen Biological Drugs Product
Table 108. Biogen Recent Developments/Updates
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Business Overview
Table 111. GlaxoSmithKline Biological Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. GlaxoSmithKline Biological Drugs Product
Table 113. GlaxoSmithKline Recent Developments/Updates
Table 114. Production Base and Market Concentration Rate of Raw Material
Table 115. Key Suppliers of Raw Materials
Table 116. Biological Drugs Distributors List
Table 117. Biological Drugs Customers List
Table 118. Biological Drugs Market Trends
Table 119. Biological Drugs Market Drivers
Table 120. Biological Drugs Market Challenges
Table 121. Biological Drugs Market Restraints
Table 122. Global Biological Drugs Sales Forecast by Type (2023-2032) & (K Units)
Table 123. Global Biological Drugs Sales Market Share Forecast by Type (2023-2032)
Table 124. Global Biological Drugs Revenue Forecast by Type (2023-2032) & (US$ Million)
Table 125. Global Biological Drugs Revenue Market Share Forecast by Type (2023-2032)
Table 126. Global Biological Drugs Sales Forecast by Application (2023-2032) & (K Units)
Table 127. Global Biological Drugs Sales Market Share Forecast by Application (2023-2032)
Table 128. Global Biological Drugs Revenue Forecast by Application (2023-2032) & (US$ Million)
Table 129. Global Biological Drugs Revenue Market Share Forecast by Application (2023-2032)
Table 130. Global Biological Drugs Sales Forecast by Region (2023-2032) & (K Units)
Table 131. Global Biological Drugs Sales Market Share Forecast by Region (2023-2032)
Table 132. Global Biological Drugs Revenue Forecast by Region (2023-2032) & (US$ Million)
Table 133. Global Biological Drugs Revenue Market Share Forecast by Region (2023-2032)
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biological Drugs
Figure 2. Global Biological Drugs Market Share by Type in 2022 & 2032
Figure 3. Therapeutic Protein Product Picture
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biological Drugs Market Share by Application in 2022 & 2032
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Others
Figure 11. Global Biological Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2032
Figure 12. Global Biological Drugs Market Size (2018-2032) & (US$ Million)
Figure 13. Global Biological Drugs Sales (2018-2032) & (K Units)
Figure 14. Biological Drugs Sales Share by Manufacturers in 2022
Figure 15. Global Biological Drugs Revenue Share by Manufacturers in 2022
Figure 16. The Global 5 and 10 Largest Biological Drugs Players: Market Share by Revenue in 2022
Figure 17. Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 18. Global Biological Drugs Sales Market Share by Region (2018-2023)
Figure 19. Global Biological Drugs Sales Market Share by Region in 2022
Figure 20. Global Biological Drugs Revenue Market Share by Region (2018-2023)
Figure 21. Global Biological Drugs Revenue Market Share by Region in 2022
Figure 22. U.S. Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. Canada Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. Germany Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. France Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. U.K. Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Italy Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Russia Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. China Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Japan Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. South Korea Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. India Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Australia Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Taiwan Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Indonesia Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Thailand Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Malaysia Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Philippines Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Vietnam Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Mexico Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Brazil Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Argentina Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Turkey Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Saudi Arabia Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. U.A.E Biological Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Sales Market Share of Biological Drugs by Type (2018-2023)
Figure 47. Manufacturing Cost Structure of Biological Drugs
Figure 48. Manufacturing Process Analysis of Biological Drugs
Figure 49. Biological Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
